Orum Therapeutics Grants Stock Options for 108,500 Shares to Five Recipients

• Orum Therapeutics granted stock options covering 108,500 common shares to five recipients on October 23, 2026.
• Director Geoffrey Harris Meyerson received options covering 22,837 shares, exercisable from October 24, 2028, through October 23, 2031.
• Four US subsidiary employees received options covering 85,663 shares, exercisable from October 24, 2028, through October 23, 2036.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orum Therapeutics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023000451), on October 23, 2026, and is solely responsible for the information contained therein.